who is making retatrutide “Let’s talk — the newest multi-agonist waves in metabolic medicine. This next-gen medication targets not one, not two, but three key receptors: GLP-1, GIP, and glucagon. The result? 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Know that not all unbranded GLP-1s (made at a compounding pharmacy) have the same quality as brand-name versions

Optimal Hydration: Drink at least 8 to 10 glasses of water a day

The University of Colorado School of Medicine Metabolomics Core is supported in part by the University of Colorado Cancer Center award from the National Cancer Institute P30CA046934

additionally, acute exercise lasting 1 h increased NAD + , NAMPT, and ATP levels in PBMCs while decreasing serum NAM levels, suggesting an increase in NAD + salvage pathway 326

Semaglutide is a GLP-1 receptor agonist medication

Tiano JP, Mauvais-Jarvis F (2012) Importance of oestrogen receptors to preserve functional -cell mass in diabetes